Discover the cancer gene therapy market's expansion to US$19.97 billion by 2033 with 19.8% CAGR. Key insights on North America's 43.5% share, gene-induced immunotherapy's 44.1% dominance, and breast cancer applications fueled by players like Novartis and copyright. https://finance.yahoo.com/news/cancer-gene-therapy-market-size-151300630.html